Chenguang Biotech will make an appointment for the disclosure of the 2023 annual report in accordanc

Mondo Finance Updated on 2024-01-30

**Star News, Chenguang Biology (300138) replied to investors' concerns on the investor relations platform on December 23.

Investors:Has the company considered raising the dividend?

Secretary of the Board of Directors of M&G:Hello, the company will formulate a profit distribution policy suitable for the long-term development of the company in accordance with the relevant provisions of the Articles of Association and the CSRC's "Regulatory Guidelines for Listed Companies No. 3 - Cash Dividends of Listed Companies", combined with the actual situation of the company, and actively return all shareholders.

Investors:May I ask the secretary of the board of directors, when will the annual report be issued?Is there a teaser?

Secretary of the Board of Directors of M&G:Hello, the company will make an appointment for the disclosure of the 2023 annual report in accordance with the requirements of the regulations. The Company will disclose its earnings forecast in accordance with regulatory requirements and in conjunction with investor recommendations. Thank you for your attention.

Investors:Xuande Bio's oil-soluble chili essence is used for "Cao's duck neck special chili essence", rather than the company's chili essence, the company's chili essence is of high quality and cheap, and it is hoped to be vigorously promoted, and it is combined with cold vegetables and marinated food.

Secretary of the Board of Directors of M&G:Hello, thank you for your recognition and suggestions to the company!Thank you for your attention.

Investors:Thumbs up for the company to double the repurchase size!There aren't many good companies like this!In addition, does the second batch of buybacks need to be authorized by a general meeting of shareholders?

Secretary of the Board of Directors of M&G:Hello, thank you for your recognition of the company!According to the company's "Announcement on the Resolution of the Third Extraordinary General Meeting of Shareholders in 2023", the general meeting of shareholders has authorized the board of directors to adjust the total amount of repurchase funds and the number of repurchases according to the specific situation of the market and the company.

The above content is compiled by **Star based on public information, generated by algorithms, and has nothing to do with the position of this site. **Star strives but does not guarantee the accuracy, completeness, validity, timeliness of all or part of the content of the information (including but not limited to text, **audio, data and charts), if there is any problem, please contact us. This article is a compilation of data and does not constitute any investment advice for you, investment is risky, please make a cautious decision.

Related Pages